Back to Search
Start Over
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
- Source :
- Cancer Reports; Apr2024, Vol. 7 Issue 4, p1-6, 6p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 25738348
- Volume :
- 7
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Cancer Reports
- Publication Type :
- Academic Journal
- Accession number :
- 176846564
- Full Text :
- https://doi.org/10.1002/cnr2.2044